Phase
Condition
N/ATreatment
transcatheter pulmonary valve implantation (TPVI)
Clinical Study ID
Ages 12-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
Patients with native RVOT (including transvalvular patch repair) are present withmoderate or greater pulmonary regurgitation with/without stenosis and are clinicallyindicated for pulmonary valve intervention.
The patient (or the patient's legally authorized representative) is willing toconsent to participate in the study and will commit to completing all follow-uprequirements.
Exclusion
Exclusion Criteria:
- Patients with any condition contraindicated by the IFU or inability to comply withthe Venus P-ValveTM System Instructions for Use or the study protocol.
Study Design
Study Description
Connect with a study center
Marie Lannelongue
le Plessis Robinson, Hauts-de-Seine 92350
FranceSite Not Available
CHU Bordeaux
Pessac, Nouvelle-Aquitaine 33600
FranceSite Not Available
Chu Nantes
Nantes, Pays de la Loire 44093
FranceActive - Recruiting
Marie Lannelongue
Le Plessis-Robinson, Île-de-France 92350
FranceActive - Recruiting
Hopital Necker-Enfants malades
Paris, Île-de-France 75015
FranceActive - Recruiting
Heart CenterMunich
Munich, Bavaria 81377
GermanySite Not Available
Clinic of Congenital Heart Disease
Berlin, 13353
GermanySite Not Available
OPBG Rome
Roma, Lazio 165
ItalySite Not Available
S. Donato Milan
Milan, Lombardy 20097
ItalySite Not Available
Leeds General Infirmary
Leeds, England LS1 3EX
United KingdomSite Not Available
Evelina Children's Hospital
London, England SE1 7EH
United KingdomSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.